Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Return on Sales: 2020-2025

Historic Return on Sales for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -0.13%.

  • Burning Rock Biotech's Return on Sales rose 113.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year increase of 113.00%. This contributed to the annual value of -0.65% for FY2024, which is 56.00% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Return on Sales stood at -0.13%, which was down 118.26% from 0.73% recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Return on Sales high stood at 0.80% for Q1 2025, and its period low was -12.78% during Q2 2023.
  • Over the past 3 years, Burning Rock Biotech's median Return on Sales value was -0.65% (recorded in 2024), while the average stood at -2.17%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by 1,103bps in 2023, then skyrocketed by 1,266bps in 2024.
  • Burning Rock Biotech's Return on Sales (Quarterly) stood at -1.57% in 2021, then slumped by 54bps to -2.10% in 2022, then soared by 67bps to -1.44% in 2023, then soared by 79bps to -0.65% in 2024, then surged by 113bps to -0.13% in 2025.
  • Its Return on Sales was -0.13% in Q3 2025, compared to 0.73% in Q2 2025 and 0.80% in Q1 2025.